Literature DB >> 1977071

Relapsing encephalomyelitis following transfer of partial immunity to JHM virus.

R A Shubin1, M A Sussman, J O Fleming, S A Stohlman.   

Abstract

Mice infected with the JHM strain mouse hepatitis virus (JHMV) develop a fatal encephalomyelitis with evidence of demyelination. It has previously been shown that the adoptive transfer of 5 x 10(7) nylon wool adherent (NWA) spleen cells from immunized donors to lethally infected recipients clears virus from the central nervous system (CNS) and prevents demyelination. Adoptive transfer of a smaller number (1 x 10(7] of NWA spleen cells from immunized donors also protects from death but does not significantly alter virus replication in the CNS during the acute phase of the infection. Moreover, these mice develop a transient non-fatal encephalomyelitis which occurs approximately 3 weeks post-infection. This delayed encephalomyelitis is associated with a mononuclear cell infiltration into the CNS but little or no evidence of virus replication or increased viral antigen. A virus-specific delayed-type hypersensitivity (DTH) response precedes this delayed onset of disease by 24 to 48 h. Resolution of disease correlates with a selective and permanent suppression of the JHMV-specific DTH reactivity. In addition, no virus-specific DTH is detected following adoptive transfer of viral-specific DTH effectors derived from immunized donors. In contrast, these mice respond to a heterologous antigen, KLH, suggesting that the resolution of the encephalitis is accompanied by a profound suppression in viral-specific DTH response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977071      PMCID: PMC7135167          DOI: 10.1016/0882-4010(90)90089-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  18 in total

1.  In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication.

Authors:  S A Stohlman; G K Matsushima; N Casteel; L P Weiner
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

2.  T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.

Authors:  M A Sussman; R A Shubin; S Kyuwa; S A Stohlman
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis.

Authors:  K Nagashima; H Wege; R Meyermann; V ter Meulen
Journal:  Acta Neuropathol       Date:  1978-10-13       Impact factor: 17.088

4.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

Authors:  H Wege; R Dörries; H Wege
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

Review 6.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

7.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

8.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  Studies on the mechanism of protection from acute viral encephalomyelitis by delayed-type hypersensitivity inducer T cell clones.

Authors:  S S Erlich; G K Matsushima; S A Stohlman
Journal:  J Neurol Sci       Date:  1989-04       Impact factor: 3.181

10.  Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.

Authors:  R Watanabe; H Wege; V ter Meulen
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more
  6 in total

1.  Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus.

Authors:  K Yokomori; S C Baker; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.

Authors:  S A Stohlman; C C Bergmann; R C van der Veen; D R Hinton
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

3.  Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes.

Authors:  N Sun; S Perlman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Acute and late disease induced by murine coronavirus, strain JHM, in a series of recombinant inbred strains between BALB/cHeA and STS/A mice.

Authors:  S Kyuwa; K Yamaguchi; Y Toyoda; K Fujiwara; J Hilgers
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

5.  Effect of persistent mouse hepatitis virus infection on MHC class I expression in murine astrocytes.

Authors:  J Correale; S Li; L P Weiner; W Gilmore
Journal:  J Neurosci Res       Date:  1995-01-01       Impact factor: 4.164

Review 6.  Immunopathological aspects of coronavirus infections.

Authors:  H Wege
Journal:  Springer Semin Immunopathol       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.